Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of substance use disorders

Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatment of substance use disorders

US Patent 11077122 · Granted Aug 3, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating a degenerative disease of the nervous system using 3-methoxy2020
Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatm2018
Non-bioconvertible C3-substituted pregnenolone derivatives for use in the treatm2018
FKBP52-Tau interaction as a novel therapeutical target for treating the neurolog2016
Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traum2016
FKBP52-Tau interaction as a novel therapeutical target for treating the neurolog2015
FKBP52-tau interaction as a novel therapeutical target for treating the neurolog2014
Use of 3-methoxy-pregnenolone for the preparation of a drug for treating depress2012
Use of 3-methoxy-pregnenolone in the production of a medicament for treating neu2011
Flushing device2004
Corticotropin-releasing factor overproducing transgenic mice2000
Mobile laser surgical center1995